Literature DB >> 11061032

Limits of a deletion spanning Tlr4 in C57BL/10ScCr mice.

A Poltorak1, I Smirnova, R Clisch, B Beutler.   

Abstract

Proceeding from our observation that LPS-unresponsive mice of the strain C57BL/10ScCr mice fail to express the Tlr4 gene [Poltorak A, He X. Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085], we have defined the exact limits of a deletion encompassing Tlr4 in the C57BL/10ScCr genome. The deletion removes 74723 bp of DNA, with reference to the control strain 129/J (from which the complete sequence of the Tlr4 locus was obtained). There is no inserted element, and no re-arrangement of the chromosome (e.g. inversion or translocation) in the immediate region of Tlr4; the deletion removes only one recognizable gene. Hence, other immunological anomalies that have been identified in C57BL/10ScCr mice (a non-healing phenotype in Leishmania inoculation and failure to produce interferon-gamma in response to numerous microbial infections) must be ascribed to one of two causes. Mutation(s) at other loci may be responsible for these defects. Alternatively, Tlr4 locus deletion may have phenotypic consequences that exceed the well known blockade of LPS signal transduction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11061032     DOI: 10.1177/09680519000060010701

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  15 in total

1.  Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4.

Authors:  Jianlin Chen; John R Hartono; Reji John; Michael Bennett; Xin Jin Zhou; Yanxia Wang; Qingqing Wu; Pamela D Winterberg; Glenn T Nagami; Christopher Y Lu
Journal:  Kidney Int       Date:  2011-06-01       Impact factor: 10.612

Review 2.  Toll-like receptors and leishmaniasis.

Authors:  Felipe F Tuon; Valdir S Amato; Hélio A Bacha; Tariq Almusawi; Maria I Duarte; Vicente Amato Neto
Journal:  Infect Immun       Date:  2007-12-10       Impact factor: 3.441

3.  Loss of TLR4 does not prevent influenza A-induced mortality.

Authors:  Luisa Morales-Nebreda; Gökhan M Mutlu; G R Scott Budinger; Kathryn A Radigan
Journal:  Am J Respir Crit Care Med       Date:  2014-05-15       Impact factor: 21.405

4.  Genetic analysis of host responses in sepsis.

Authors:  Bruce Beutler; Richard J Ulevitch
Journal:  Curr Infect Dis Rep       Date:  2007-10       Impact factor: 3.725

5.  Toll-like receptor-4 mediates intestinal barrier breakdown after thermal injury.

Authors:  Carrie Y Peterson; Todd W Costantini; William H Loomis; James G Putnam; Paul Wolf; Vishal Bansal; Brian P Eliceiri; Andrew Baird; Raul Coimbra
Journal:  Surg Infect (Larchmt)       Date:  2010-04       Impact factor: 2.150

6.  Polymorphisms in toll-like receptor 4 underlie susceptibility to tumor induction by the mouse polyomavirus.

Authors:  Palanivel Velupillai; Chang Kyoo Sung; Erik Andrews; Jennifer Moran; David Beier; Jonathan Kagan; Thomas Benjamin
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

7.  Toll-like receptor 4 (TLR4)-deficient murine macrophage cell line as an in vitro assay system to show TLR4-independent signaling of Bacteroides fragilis lipopolysaccharide.

Authors:  Eva Lorenz; Dhavalkumar D Patel; Thomas Hartung; David A Schwartz
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

8.  Cross-talk between toll-like receptor 4 (TLR4) and proteinase-activated receptor 2 (PAR(2) ) is involved in vascular function.

Authors:  M Bucci; V Vellecco; L Harrington; V Brancaleone; F Roviezzo; G Mattace Raso; A Ianaro; G Lungarella; R De Palma; R Meli; G Cirino
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

9.  Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major.

Authors:  Pascale Kropf; Marina A Freudenberg; Manuel Modolell; Helen P Price; Shanti Herath; Simone Antoniazi; Chris Galanos; Deborah F Smith; Ingrid Müller
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity.

Authors:  Stefan F Martin; Jan C Dudda; Eva Bachtanian; Annalisa Lembo; Stefanie Liller; Christoph Dürr; Markus M Heimesaat; Stefan Bereswill; György Fejer; Ralitsa Vassileva; Thilo Jakob; Nikolaus Freudenberg; Christian C Termeer; Caroline Johner; Chris Galanos; Marina A Freudenberg
Journal:  J Exp Med       Date:  2008-08-25       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.